<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00987441</url>
  </required_header>
  <id_info>
    <org_study_id>NJMU-0933MZ</org_study_id>
    <secondary_id>NMUK2191</secondary_id>
    <nct_id>NCT00987441</nct_id>
  </id_info>
  <brief_title>Epidural Labor Analgesia and Infant Neurobehavior</brief_title>
  <acronym>ELAIN</acronym>
  <official_title>Epidural Analgesia for Labor Pain and Infant Neurobehavior</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infant neurobehavior alteration is predictor of later intelligence development. Many factors
      would influence or are associated with infant neurobehavior, of which exist or appear during
      perinatal period. Neuraxial, especially epidural, analgesia to date is the most effective
      method in relieving labor pain. Although previous studies showed that opioid used in epidural
      analgesia for labor pain can affect newborn neurobehavior negatively in a dose-escalation
      associated manner, whether epidural analgesia itself would produce unpredictable effect on
      newborn neurobehavior is still unknown. Hereby the investigators designed this trial to
      investigate the hypothesis that epidural analgesia for labor pain control itself would not
      produce negative effect on infant neurobehavior.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)</measure>
    <time_frame>Immediate after birth (0 min)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Apgar scoring</measure>
    <time_frame>One min and 5min after birth.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical-cord gases analysis</measure>
    <time_frame>At the time baby was born (0min)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal sepsis evaluation</measure>
    <time_frame>One hour after the baby was born</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal antibiotic treatment</measure>
    <time_frame>One hour after the baby was born</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of maternal side effects</measure>
    <time_frame>Analgesia initiation (0min) to successful vaginal delivery (this time encountered alteration with different women)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)</measure>
    <time_frame>10min after birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)</measure>
    <time_frame>1h after birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)</measure>
    <time_frame>8h after birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)</measure>
    <time_frame>1d after birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)</measure>
    <time_frame>1wk after birth</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">1200</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>Local anesthetic plus opioid 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Local anesthetic (ropivacaine 0.125%) plus first opioid dose (sufentanil 0.3 microgram/ml) delivered peridural space</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic plus opioid 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Local anesthetic (ropivacaine 0.125%) plus second opioid dose (sufentanil 0.4 microgram/ml) delivered peridural space</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic plus opioid 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Local anesthetic (ropivacaine 0.125%) plus third opioid dose (sufentanil 0.5 microgram/ml) delivered peridural space</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic 1 plus opioid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>First local anesthetic dose (ropivacaine 0.0625%) plus opioid (sufentanil 0.4 microgram/ml) delivered peridural space</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic 2 plus opioid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Second local anesthetic dose (ropivacaine 0.1875%) plus opioid (sufentanil 0.4 microgram/ml) delivered peridural space</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anesthetic 3 plus opioid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Third local anesthetic dose (ropivacaine 0.25%) plus opioid (sufentanil 0.4 microgram/ml) delivered peridural space</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine and sufentanil</intervention_name>
    <description>Ropivacaine 0.125% plus sufentanil 0.3 microgram</description>
    <arm_group_label>Local anesthetic plus opioid 1</arm_group_label>
    <other_name>Naropin</other_name>
    <other_name>Sufenil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine and sufentanil</intervention_name>
    <description>Ropivacaine 0.125% plus sufentanil 0.4 microgram</description>
    <arm_group_label>Local anesthetic plus opioid 2</arm_group_label>
    <other_name>Naropin</other_name>
    <other_name>Sufenil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine and sufentanil</intervention_name>
    <description>Ropivacaine 0.125% plus sufentanil 0.5 microgram</description>
    <arm_group_label>Local anesthetic plus opioid 3</arm_group_label>
    <other_name>Naropin</other_name>
    <other_name>Sufenil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine and sufentanil</intervention_name>
    <description>Ropivacaine 0.0625% plus sufentanil 0.4 microgram</description>
    <arm_group_label>Local anesthetic 1 plus opioid</arm_group_label>
    <other_name>Naropin</other_name>
    <other_name>Sufenil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine and sufentanil</intervention_name>
    <description>Ropivacaine 0.1875% plus sufentanil 0.4 microgram</description>
    <arm_group_label>Local anesthetic 2 plus opioid</arm_group_label>
    <other_name>Naropin</other_name>
    <other_name>Sufenil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine and sufentanil</intervention_name>
    <description>Ropivacaine 0.25% plus sufentanil 0.4 microgram</description>
    <arm_group_label>Local anesthetic 3 plus opioid</arm_group_label>
    <other_name>Naropin</other_name>
    <other_name>Sufenil</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18years and &lt;45years

          -  Spontaneous labor

          -  Analgesia request

        Exclusion Criteria:

          -  Allergy to opioids, a history of the use of centrally-acting drugs of any sort,
             chronic pain and psychiatric diseases records

          -  Participants younger than 18 years or older than 45 years

          -  Those who were not willing to or could not finish the whole study at any time

          -  Using or used in the past 14 days of the monoamine oxidase inhibitors

          -  Alcohol addictive or narcotic dependent patients were excluded for their influence on
             the analgesic efficacy of the epidural analgesics

          -  Subjects with a nonvertex presentation or scheduled induction of labor
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XiaoFeng Shen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Affiliated Nanjing Maternity and Child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2009</study_first_submitted>
  <study_first_submitted_qc>September 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2009</study_first_posted>
  <last_update_submitted>July 26, 2011</last_update_submitted>
  <last_update_submitted_qc>July 26, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2011</last_update_posted>
  <responsible_party>
    <name_title>XiaoFeng Shen</name_title>
    <organization>Nanjing Medical University</organization>
  </responsible_party>
  <keyword>Neurobehavior</keyword>
  <keyword>Epidural analgesia</keyword>
  <keyword>Local anesthetic</keyword>
  <keyword>Opioid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

